Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Raymond John Barlow Insider Profile
4 Followers
Raymond John Barlow, Chief Executive Officer at E Therapeutics, holds 1.45M shares in E Therapeutics (Ticker: GB:ETX). Most recently, Raymond John Barlow Bought 250,000p shares of E Therapeutics on Apr 02, 2019 for an estimated value of 7.00K.
Raymond John Barlow E Therapeutics (ETX)Chief Executive Officer
E Therapeutics (ETX)
Chief Executive Officer
Ranked #18,266 out of 97,997 Corporate Insiders
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
+25.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Raymond John Barlow does not currently own shares as a corporate insider.
A breakdown of Raymond John Barlow's holdings
Insider Roles
Raymond John Barlow does not currently hold a role as a corporate insider.
Roles that Raymond John Barlow holds in companies
Most Profitable Insider Trade
Stock:
E Therapeutics
(ETX)
(ETX)
Rating:Informative Buy
Date:Apr 02, 2019 - Apr 02, 2020
Return:+172.50%
The most profitable trade made by Raymond John Barlow
Raymond John Barlow's Trading History
List of latest transactions for each holding click on a transaction to see Raymond John Barlow's performance on stock
You May Also Like
Raymond John Barlow insider profile FAQ
What is the percentage of profitable transactions made by Raymond John Barlow?
The percentage of profitable transactions made by Raymond John Barlow is 25%.
What is the average return per transaction made by Raymond John Barlow?
The average return per transaction made by Raymond John Barlow is 25.90%.
What stocks does Raymond John Barlow hold?
Raymond John Barlow holds: GB:ETX stocks.
What was Raymond John Barlow’s latest transaction?
Raymond John Barlow latest transaction was an Informative Buy of 7.00K.
What was Raymond John Barlow's most profitable transaction?
Raymond John Barlow’s most profitable transaction was an Informative Buy of GB:ETX stock on April 2, 2019. The return on the trade was 172.50%.
What is Raymond John Barlow's role in E Therapeutics?
Raymond John Barlow's role in E Therapeutics is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.